PT3139948T - Treatment of diabetes type 1 using glp-1 and anti-il-21 - Google Patents

Treatment of diabetes type 1 using glp-1 and anti-il-21

Info

Publication number
PT3139948T
PT3139948T PT157209826T PT15720982T PT3139948T PT 3139948 T PT3139948 T PT 3139948T PT 157209826 T PT157209826 T PT 157209826T PT 15720982 T PT15720982 T PT 15720982T PT 3139948 T PT3139948 T PT 3139948T
Authority
PT
Portugal
Prior art keywords
glp
treatment
diabetes type
diabetes
type
Prior art date
Application number
PT157209826T
Other languages
Portuguese (pt)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PT3139948T publication Critical patent/PT3139948T/en

Links

PT157209826T 2014-05-07 2015-05-05 Treatment of diabetes type 1 using glp-1 and anti-il-21 PT3139948T (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461989841P 2014-05-07 2014-05-07
EP14169596 2014-05-23
EP14189732 2014-10-21

Publications (1)

Publication Number Publication Date
PT3139948T true PT3139948T (en) 2020-05-22

Family

ID=70609983

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157209826T PT3139948T (en) 2014-05-07 2015-05-05 Treatment of diabetes type 1 using glp-1 and anti-il-21

Country Status (6)

Country Link
JP (1) JP6824373B2 (en)
DK (1) DK3139948T3 (en)
ES (1) ES2791879T3 (en)
HR (1) HRP20200763T1 (en)
HU (1) HUE048860T2 (en)
PT (1) PT3139948T (en)

Also Published As

Publication number Publication date
HRP20200763T1 (en) 2020-07-24
ES2791879T3 (en) 2020-11-06
HUE048860T2 (en) 2020-09-28
JP2020073501A (en) 2020-05-14
JP6824373B2 (en) 2021-02-03
DK3139948T3 (en) 2020-05-25

Similar Documents

Publication Publication Date Title
HRP20190369T1 (en) Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity
HK1243073A1 (en) Therapeutic compounds and uses thereof
IL246757B (en) Novel insulin derivatives and the medical uses hereof
HUE057301T2 (en) Treatment of post-bariatric hypoglycemia with glp-1 antagonists
IL283335B (en) Dihydropyrimidin-2-one compounds and medical use thereof
HK1244216A1 (en) Treatment type 2 diabetes mellitus patients
GB201612165D0 (en) Combinations for the treatment of type 2 diabetes
HK1251449A1 (en) Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes
IL254500A0 (en) Treatment of type 2 diabetes mellitus patients
GB201403996D0 (en) Traditional chinese medicine composition for the treatment of diabetes
RS60316B1 (en) Treatment of diabetes type 1 using glp-1 and anti-il-21
HK1244821A1 (en) Peptides for use in treatment and diagnosis of type 1 diabetes
GB201707207D0 (en) Treatment of type 1 diabetes
IL250666B (en) Peptide for treatment of type 2 diabetes mellitus and its complications
HK1257593A1 (en) New drug for treating diabetes and use thereof
HUE048860T2 (en) Treatment of diabetes type 1 using glp-1 and anti-il-21
GB201513543D0 (en) Compositions for use in the treatment of diabetes
GB201418541D0 (en) Materials for use with general hyperthermia treatment
SG10201400823PA (en) Therapeutic methods and compositions for treating diabetes
GB201417777D0 (en) Novel compounds and therapeutic uses thereof